XR Securities LLC - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 160 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.51 and the average weighting 0.1%.

Quarter-by-quarter ownership
XR Securities LLC ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q4 2020$2,000
-66.7%
25,8000.0%0.00%
Q3 2020$6,000
-68.4%
25,800
-2.3%
0.00%
-100.0%
Q2 2020$19,000
+11.8%
26,4000.0%0.00%
+100.0%
Q1 2020$17,000
-22.7%
26,400
+4.8%
0.00%
-66.7%
Q4 2019$22,000
+10.0%
25,200
-0.4%
0.00%0.0%
Q3 2019$20,000
+566.7%
25,300
+105.7%
0.00%
+200.0%
Q3 2018$3,00012,3000.00%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q4 2020
NameSharesValueWeighting ↓
Third Security, LLC 17,815,708$47,033,0002.93%
Essex Woodlands Management, Inc. 2,764,908$7,130,0002.60%
Belmont Global Advisors, Inc. 973,000$2,569,0002.01%
Belmont Global Advisors, Inc. 135,700$358,0000.28%
MSD Partners, L.P. 2,750,000$7,260,0000.22%
SFMG, LLC 99,850$264,0000.08%
Rotella Capital Management, Inc. 11,090$29,0000.03%
WESTPORT RESOURCES MANAGEMENT INC 33,500$88,0000.02%
SMITH ASSET MANAGEMENT GROUP LP 236,590$625,0000.02%
FRANKLIN STREET ADVISORS INC /NC 41,150$109,0000.02%
View complete list of ZIOPHARM ONCOLOGY INC shareholders